CN103784946B - A kind of pharmaceutical composition treating condyloma acuminatum - Google Patents
A kind of pharmaceutical composition treating condyloma acuminatum Download PDFInfo
- Publication number
- CN103784946B CN103784946B CN201410056312.4A CN201410056312A CN103784946B CN 103784946 B CN103784946 B CN 103784946B CN 201410056312 A CN201410056312 A CN 201410056312A CN 103784946 B CN103784946 B CN 103784946B
- Authority
- CN
- China
- Prior art keywords
- herba
- radix
- pharmaceutical composition
- condyloma acuminatum
- stone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a kind of pharmaceutical composition treating condyloma acuminatum, it is characterised in that its raw material medicines in portions by weight is as follows: Radix Salviae Miltiorrhizae 6��9g, Semen Ricini 9��12g, Squama Manis 3��6g, Matrii Sulfas Exsiccatus 4��6g, spend stone 4��6g of heap of stone, Fructus Gardeniae 6��9g, Herba Hyperici Japonici 4��6g, Herba Artemisiae Anomalae 6��9g, Radix Paeoniae Rubra 4��6g, Herba pterocephali 2��3g. Above all levigation end Oleum Radix Arnebiae (Oleum Radix Lithospermi) 50 milliliters are mixed well standby. Interferon: 1,000,000 U subcutaneously or intramuscularly inject, the next day or weekly injection 2 times. Useful effect of Chinese medicine of the present invention is: heat-clearing and toxic substances removing, hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, can thoroughly remove the virus under local skin mucosa while dispelling body surface wart body, improves immunity, systematic treating, reaches thorough radical cure and do not recur.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition treating condyloma acuminatum.
Background technology
Condyloma acuminatum is to be infected the caused sexually transmitted disease (STD) being main manifestations with anus genital area hyperplastic lesions by human papillomavirus (HPV). Mostly betide the young people of 18��50 years old. Approximately pass through two weeks to 8 months, average out to sequela incubation period of 3 months. This disease is relatively conventional, mainly through transmission through sex. The HPV the most often causing condyloma acuminatum has 6,11 etc. HPV is easy survival and reproduction when human body warm moist, therefore external genitalia and crissum are the positions being easiest to infect.
Summary of the invention
Useful effect of Chinese medicine of the present invention is: heat-clearing and toxic substances removing, hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, can thoroughly remove the virus under local skin mucosa while removing body surface wart body, improves immunity, systematic treating, reaches thorough radical cure and do not recur.
The technical problem to be solved is to overcome technical deficiency, it is provided that a kind of good effect, short treating period, remission rate is high, and cost is low, a kind of pharmaceutical composition treating condyloma acuminatum having no side effect.
For above-mentioned purpose, a kind of pharmaceutical composition treating condyloma acuminatum, it is characterized in that its raw material medicines in portions by weight is as follows: Radix Salviae Miltiorrhizae 6��9g, Semen Ricini 9��12g, Squama Manis 3��6g, Matrii Sulfas Exsiccatus 4��6g, spend stone 4��6g of heap of stone, Fructus Gardeniae 6��9g, Herba Hyperici Japonici 4��6g, Herba Artemisiae Anomalae 6��9g, Radix Paeoniae Rubra 4��6g, Herba pterocephali 2��3g, above all levigation end Oleum Radix Arnebiae (Oleum Radix Lithospermi) 50 milliliters are mixed well standby. Interferon: 1,000,000 U subcutaneously or intramuscularly inject, the next day or weekly injection 2 times.
Radix Salviae Miltiorrhizae bitter in the mouth in Chinese medicine of the present invention, feeble QI is trembled with fear, nontoxic. Enter the heart, spleen two warp. Promoting blood circulation to restore menstrual flow, evacuation of pus granulation promoting, special regulating menstruation arteries and veins, reason iliacus is ached, and tissue regeneration promoting blood removes stagnant blood. " book on Chinese herbal medicine is looked for the truth ": Radix Salviae Miltiorrhizae, book load can enter percardium removing blood stasis with potent drugs one language, has use up Radix Salviae Miltiorrhizae effect. So have opinion its can tissue regeneration promoting antiabortive, regulating menstruation relieving restlessness, sedate of reposing, and all migratory arthralgia, metrorrhagia and leukorrhagia, lump in the abdomen, conjunctival congestion, colic, skin ulcer scabies the disease such as swell and ache. Semen Ricini belongs to the seed of euphorbia plant Semen Ricini, and function cures mainly: detumescence and drawing out poison;Rush down lower intestinal stasis relieving; Dredging collateral profit key. Main swollen ulcer drug; Scrofula, acute mastitis, sore throat, mange tinea skin ulcer, scald, edema distension, traumatic injury. Squama Manis salty in the mouth, cold nature. Return liver, stomach warp. Function with cure mainly: the abdominal mass that disappears of invigorating blood circulation, stimulating milk secretion of stimulating the menstrual flow, detumescence and apocenosis, search wind and removing obstruction in channels. For carbuncle sore tumefacting virus, rheumatic arthralgia .... It is prepared that Matrii Sulfas Exsiccatus is that Natrii Sulfas dries through air slaking. Main sulfur acid sodium. Function with cure mainly: relieving constipation by purgation, moistening for dryness and softening hard mass, detumescence of relieving inflammation or internal heat. External treatment laryngopharynx swelling and pain, aphtha of the mouth and tongue, gingival swelling and pain, conjunctival congestion, carbuncle, erysipelas. Spend stone sour in the mouth of heap of stone, puckery, property put down. Return Liver Channel. Merit Bears with cure mainly: removing stasis to stop bleeding. Fructus Gardeniae heat clearing away, pathogenic fire purging, removing heat from blood. Modern study, has antibacterial, antiinflammatory and the effect for the treatment of soft tissue injury. Herba Hyperici Japonici is the herb of Garcinia maingayii Herba Hyperici Japonici. Clearing away heat-damp and promoting diuresis, removing toxic substances, dissipating blood stasis for subsidence of swelling. Main jaundice due to damp-heat; Carbuncle furuncle and phyma poison, tonsillitis, aphtha, conjunctival congestion and swelling pain, venom, traumatic injury. Bacteriostasis: in vitro tests, Common Pathogenic fungus is had obvious inhibiting effect by Herba Hyperici Japonici decoct. Herba Artemisiae Anomalae this product is the dry herb of goatweed Herba Siphonostegiae. Function with cure mainly: blood circulation promoting and blood stasis dispelling, inducing menstruation to relieve menalgia, removing heat from blood, hemostasis, clearing away heat-damp and promoting diuresis. Radix Paeoniae Rubra bitter in the mouth, cold in nature. Return spleen, stomach, liver, gallbladder meridian. Function cures mainly: clots absorbing, pain relieving, removing heat from blood, detumescence. For maculae caused by violent heat pathogen, injury from falling down, carbuncle skin infection .... Herba pterocephali this product is Dipsacaceae plant spoon leaf Herba pterocephali. Function with cure mainly: removing toxic substances is except pestilence, and dispel the wind blood stasis dispelling. Oleum Radix Arnebiae (Oleum Radix Lithospermi) has effect of box set, convergence. Above compatibility of drugs, bring out the best in each other.
The present invention follows the prescription principle of the traditional Chinese medical science, and be decocted in water for oral dose use, through clinical application for many years verify, total effective rate 96.7%, cure rate 83.8%, have no side effect.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described:
Embodiment 1: a kind of pharmaceutical composition treating condyloma acuminatum, it is characterised in that its raw material medicines in portions by weight is as follows: Radix Salviae Miltiorrhizae 6��9g, Semen Ricini 9��12g, Squama Manis 3��6g, Matrii Sulfas Exsiccatus 4��6g, spend stone 4��6g of heap of stone, Fructus Gardeniae 6��9g, Herba Hyperici Japonici 4��6g, Herba Artemisiae Anomalae 6��9g, Radix Paeoniae Rubra 4��6g, Herba pterocephali 2��3g. By all levigation end is standby above. Above all levigation end Oleum Radix Arnebiae (Oleum Radix Lithospermi) 50 milliliters are mixed well standby. Interferon: 1,000,000 U subcutaneously or intramuscularly inject, the next day or weekly injection 2 times.
Embodiment 2: a kind of pharmaceutical composition treating condyloma acuminatum, it is characterised in that its raw material medicines in portions by weight is as follows: Radix Salviae Miltiorrhizae 9g, Semen Ricini 12g, Squama Manis 3g, Matrii Sulfas Exsiccatus 4g, spend stone 4g of heap of stone, Fructus Gardeniae 9g, Herba Hyperici Japonici 6g, Herba Artemisiae Anomalae 6g, Radix Paeoniae Rubra 6g, Herba pterocephali 2g. Above all levigation end Oleum Radix Arnebiae (Oleum Radix Lithospermi) 50 milliliters are mixed well deposited affected part, every day 2 times, each 30 minutes. Interferon: 1,000,000 U subcutaneously or intramuscularly inject, the next day or weekly injection 2 times.
Clinical efficacy is summed up:
One, physical data: we are extensive in clinical practice for many years, treat female patient 66 example, the age at 31��56 years old, average 39.2 years old. Curative effect frequency is good. It is not taken by pregnant women.
Two, diagnostic criteria: sexual contact history or mediate contact infect history, typical case's skin lesion is that the moist position such as genitals or crissum pimple, mamillary, cauliflower form or cockscomb shape meat vegetation, rough surface keratinization occurs. 2. auxiliary examination: Acetic acid test is positive, and nucleic acid hybridization can detect HPV-DNA correlated series, PCR detects visible specificity HPV-DNA and expands zone etc.3. patient has unclean sexual life history or spouse to infect history more, and minority condyloma acuminatum is infected by the apparatus of contact stain, and it is infected that neonate also can pass through birth canal. 1��8 month incubation period not etc., average out to 3 months.
Three, method of administration: above all levigation end Oleum Radix Arnebiae (Oleum Radix Lithospermi) 50 milliliters are mixed well standby. , adult every day 1 dose, every dose of pan-fried 200ml, early, evening sub-service, every 10 days was 1 course for the treatment of. Interferon injection: 1,000,000 U subcutaneously or intramuscularly inject 1 month, the next day or weekly injection 2 times.
Four, curative effect judging standard
Cure: clinical symptoms is wholly absent.
Take a turn for the better: clinical symptoms is improved.
Invalid: clinical symptoms is unchanged or increases the weight of.
Five, therapeutic effect: the present invention, for many years in clinical practice, treats 66 example patients, cures 52 examples 83.8%, and take a turn for the better 9 examples, is 12.9%; Invalid 1 example. Total effective rate 96.7%, cure rate 83.8%.
Six, model case
1, Rhizoma Zingiberis Recens ����, female, 32 years old, in June, 2010 went to a doctor. Skin lesion, perineum and crissum mamillary meat vegetation, rough surface keratinization 2 months occur under main suit's breast. Lab testing: Acetic acid test is positive. Patient requests applies 20 doses of external applications of Chinese medicine of the present invention, disturb element injection: 1,000,000 U subcutaneously or intramuscularly inject 1 month, the next day or weekly injection 2 times. Clinical symptoms is wholly absent, and follows up a case by regular visits to and do not recur again after half a year.
2, Lee's ����, female, 39 years old, in JIUYUE, 20110 was gone to a doctor, and main suit has spouse to infect history, and skin lesion, mamillary meat vegetation, rough surface keratinization 2 months occurs in crissum. Lab testing: the acetic acid white experiment positive. Patient requests applies 20 doses of external applications of Chinese medicine of the present invention, disturb element injection: 1,000,000 U subcutaneously or intramuscularly inject 1 month, the next day or weekly injection 2 times. Clinical symptoms is wholly absent, and follows up a case by regular visits to and do not recur again after half a year.
3, high ��, man, 22 years old, in November, 2012 went to a doctor. There is skin lesion, mamillary meat vegetation, rough surface keratinization 2 months in main suit's crissum. Lab testing: Acetic acid test is positive. Patient requests applies 20 doses of external applications of Chinese medicine of the present invention, disturb element injection: 1,000,000 U subcutaneously or intramuscularly inject 1 month, the next day or weekly injection 2 times. Clinical symptoms is wholly absent, and follows up a case by regular visits to and do not recur again after half a year.
Claims (1)
1. the pharmaceutical composition treating condyloma acuminatum, it is characterized in that its raw material medicines in portions by weight is as follows: Radix Salviae Miltiorrhizae 6��9g, Semen Ricini 9��12g, Squama Manis 3��6g, Matrii Sulfas Exsiccatus 4��6g, Ophicalcitum 4��6g, Fructus Gardeniae 6��9g, Herba Hyperici Japonici 4��6g, Herba Artemisiae Anomalae 6��9g, Radix Paeoniae Rubra 4��6g, Herba pterocephali 2��3g, above all levigation end Oleum Radix Arnebiae (Oleum Radix Lithospermi) 50 milliliters are mixed well standby.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410056312.4A CN103784946B (en) | 2014-02-16 | 2014-02-16 | A kind of pharmaceutical composition treating condyloma acuminatum |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410056312.4A CN103784946B (en) | 2014-02-16 | 2014-02-16 | A kind of pharmaceutical composition treating condyloma acuminatum |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103784946A CN103784946A (en) | 2014-05-14 |
CN103784946B true CN103784946B (en) | 2016-06-08 |
Family
ID=50661281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410056312.4A Expired - Fee Related CN103784946B (en) | 2014-02-16 | 2014-02-16 | A kind of pharmaceutical composition treating condyloma acuminatum |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103784946B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1418685A (en) * | 2002-11-29 | 2003-05-21 | 张慧芳 | Medicine composition for treating and its prepn. method |
CN1915348A (en) * | 2006-08-17 | 2007-02-21 | 胡国良 | Medication of medical broth for treating congestion type condyloma acuminatum, and preparation method |
CN102366567A (en) * | 2011-10-12 | 2012-03-07 | 王世勋 | Pharmaceutical composition for treating condyloma acuminatum, and preparation and application method |
-
2014
- 2014-02-16 CN CN201410056312.4A patent/CN103784946B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1418685A (en) * | 2002-11-29 | 2003-05-21 | 张慧芳 | Medicine composition for treating and its prepn. method |
CN1915348A (en) * | 2006-08-17 | 2007-02-21 | 胡国良 | Medication of medical broth for treating congestion type condyloma acuminatum, and preparation method |
CN102366567A (en) * | 2011-10-12 | 2012-03-07 | 王世勋 | Pharmaceutical composition for treating condyloma acuminatum, and preparation and application method |
Non-Patent Citations (1)
Title |
---|
"中西医结合治疗尖锐湿疣62例";汪玉梅;《中国医学文摘-皮肤科学》;20100430;第27卷(第2期);第77-78页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103784946A (en) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102755426B (en) | Chinese medicament for treating gynecological inflammation and preparation method | |
CN101085271B (en) | Oral administration traditional Chinese medicine composition for curing chronic pelvic inflammatory disease | |
CN104189871A (en) | Medicated wine for treating osteoproliferation | |
CN101129868A (en) | Orally taken traditional Chinese medicine composition for treating chronic pelvic inflammatory disease | |
CN104721749A (en) | Traditional Chinese medicine cleaning solution for treating puerperal infection and preparation method of traditional Chinese medicine cleaning solution | |
CN103908600B (en) | The external used medicine for the treatment of rheumatoid arthritis damp-heat arthralgia resistance card and preparation method | |
CN103007093A (en) | Medicine for treating gynecological inflammation and preparation method thereof | |
CN102764360B (en) | Traditional Chinese medicine composition for treating acute cystitis | |
CN105362839A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
CN102772699B (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease | |
CN104825921A (en) | External-use traditional Chinese medicine for treating eczema | |
CN104147252A (en) | Traditional Chinese medicine preparation for treating hepatitis | |
CN103784946B (en) | A kind of pharmaceutical composition treating condyloma acuminatum | |
CN103784806B (en) | A kind of Chinese medicine treating anemopyretic urticaria | |
CN102949467A (en) | Medicinal composition for treating chronic pelvic inflammation caused by dampness and hotness obstruction | |
CN103933429A (en) | Traditional Chinese medicine composition for treating vaginitis | |
CN104398613A (en) | Traditional Chinese medicine for treating hemorrhoid | |
CN104189477A (en) | Traditional Chinese medicine formula for treating barbiers | |
CN104274617A (en) | Traditional Chinese medicine composition for nursing treatment of acute cervicitis | |
CN102688456B (en) | Chinese medicinal composition for treating chronic prostatitis | |
CN103285177A (en) | Externally used paste for treating bedsore and furuncle | |
CN105999033A (en) | Traditional Chinese medicine composition for nursing chronic rhinitis | |
CN103933390B (en) | Traditional Chinese medicinal preparation for treating breast cystic hyperplasia | |
CN104740528B (en) | A kind of traditional Chinese medicine powder for treating cervicitis | |
CN104147408A (en) | External traditional Chinese medicament for treating hyperostosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160608 Termination date: 20220216 |
|
CF01 | Termination of patent right due to non-payment of annual fee |